Evidence map›Paper›PMID 22718751›Full record

ArticleThe Journal of biological chemistry2012

Dynamin-mediated Nephrin phosphorylation regulates glucose-stimulated insulin release in pancreatic beta cells.

Jongmin Jeon, Ingo Leibiger, Tilo Moede, Britta Walter, Christian Faul, Dony Maiguel, Rodrigo Villarreal, Johanna Guzman, Per-Olof Berggren, Peter Mundel and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The human nephrin YThe Journal of biological chemistry · 2019
    Article
  3. Journal of the American Society of Nephrology : JASN · 2018
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.Journal of the American Society of Nephrology : JASN · 2014
    Article
  12. The function of endocytosis in podocytes.Current opinion in nephrology and hypertension · 2013
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jongmin JeonDiabetes Research Institute, University of Miami L. Miller School of Medicine, Miami, Florida 33136, USA.
Ingo Leibiger
Tilo Moede
Britta Walter
Christian Faul
Dony Maiguel
Rodrigo Villarreal
Johanna Guzman
Per-Olof Berggren
Peter Mundel
Camillo Ricordi
Sandra Merscher-Gomez
Alessia Fornoni
University of Miami · USKarolinska Institutet · SEHarvard University · US

Funding

Strategies to Improve Long Term Islet Graft SurvivalU01DK070460 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2004 to 2012
$11.6M
ISLET CELL RESOURCE FOR DIABETES RESEARCH AND TREATMENTU42RR016603 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2001 to 2009
$7.8M
CELL AND MOLECULAR BIOLOGICAL ANALYSIS OF SYNAPTOPODINR01DK057683 · NIDDK · YESHIVA UNIVERSITY · PI SOBERMAN, ROY · 2001 to 2015
$4.8M
Regulation of podocyte function by hic-5R01DK091218 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MUNDEL, PETER H · 2012 to 2015
$1.5M
Role of nephrin in pancreatic beta cell functionK08DK082636 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FORNONI, ALESSIA · 2009 to 2011
$434k
NCRR NIH HHS U42 RR016603NIDDK NIH HHS DK70460NIDDK NIH HHS DK82636NIDDK NIH HHS K08 DK082636NIDDK NIH HHS R01 DK057683NIDDK NIH HHS R01 DK091218NIDDK NIH HHS U01 DK070460
6 · The paper itself

Abstract

We have previously demonstrated a role for Nephrin in glucose stimulated insulin release (GSIR). We now hypothesize that Nephrin phosphorylation is required for GSIR and that Dynamin influences Nephrin phosphorylation and function. MIN6-C3 Nephrin-deficient pancreatic beta cells and human islets were transfected with WT-Nephrin or with a mutant Nephrin in which the tyrosine residues responsible for SH2 domain binding were substituted with phenylalanine (3YF-Nephrin). GSIR and live images of Nephrin and vesicle trafficking were studied. Immunoprecipitation experiments and overexpression of WT-Dynamin or dominant negative Dynamin mutant (K44A-Dynamin) in WT-Nephrin, 3YF-Nephrin, or Nephrin siRNA-transfected cells were utilized to study Nephrin-Dynamin interaction. In contrast to WT-Nephrin or to single tyrosine mutants, 3YF-Nephrin did not positively affect GSIR and led to impaired cell-cell contacts and vesicle trafficking. K44A-Dynamin prevented the effect of Nephrin on GSIR in the absence of protein-protein interaction between Nephrin and Dynamin. Nephrin gene silencing abolished the positive effects of WT-Dynamin on GSIR. The effects of protamine sulfate and vanadate on Nephrin phosphorylation and GSIR were studied in MIN6 cells and human islets. WT-Nephrin phosphorylation after glucose occurred at Tyr-1176/1193 and resulted in improved GSIR. On the contrary, protamine sulfate-induced phosphorylation at Tyr-1176/1193/1217 was associated with Nephrin degradation and impaired GSIR. Vanadate, which prevented Nephrin dephosphorylation after glucose stimulation, improved GSIR in human islets and MIN6 cells. In conclusion, Dynamin-dependent Nephrin phosphorylation occurs in response to glucose and is necessary for Nephrin-mediated augmentation of GSIR. Pharmacological modulation of Nephrin phosphorylation may thus facilitate pancreatic beta cell function.

Indexed as

ProteolysisAmino Acid SubstitutionDynaminsGene SilencingGlucoseHEK293 CellsHumansInsulinInsulin-Secreting CellsInsulin SecretionMembrane ProteinsMutation, MissensePhosphorylationSweetening AgentsVanadatesDynaminsGlucoseInsulinMembrane ProteinsnephrinSweetening AgentsVanadates

Identifiers

PMID22718751
PMCPMC3436561
OpenAlexW2015657283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.